Inflammatory bowel disease (IBD) is characterized by dysregulated immune response, ultimately leading to barrier damage. Unfortunately, conventional research models are not capable of capturing this complexity, resulting in an incomplete understanding of disease biology and high clinical trial attrition.
In this video, see how Emulate Organ-Chips offer an unparalleled window into IBD human immune response. By incorporating critical features of the human tissue microenvironment, Organ-Chips enable researchers to model the complexity of immune cell recruitment in a tissue-, disease-, and species-specific manner, and evaluate the efficacy of clinically relevant drug candidates.